Atlas Trials

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

Clinical trial NCT05670561 · UNKNOWN

Trial details

NCT number
NCT05670561
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationPain
Start date
2023-01-05
Primary completion
2023-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.